Rare diseases
Investigational molecules
Locations
High-Tech Industrial Park, 5 -190 Yunhan Drive, Shuitu, 400714
Respirent Pharmaceuticals Co. Ltd. focuses on respiratory medicine, with clinical research centred on inhaled therapies used in the regular treatment of bronchial asthma and in the maintenance management of chronic obstructive pulmonary disease (COPD). Its trial activity reflects interest in medicines that support long-term control of airflow obstruction and symptom relief in chronic airway disease.
The sponsor’s research landscape includes inhaled combination treatments containing a corticosteroid and a long-acting beta2-adrenergic agonist (LABA), indicating a therapeutic focus on established controller therapies for chronic respiratory conditions.
Respirent Pharmaceuticals Co. Ltd. runs clinical trials in conditions such as Asthma, Chronic obstructive pulmonary disease, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
GreeceGreeceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
